Dr. Yuanpei Li is the Founder and CEO of Theranostec Inc. He is a Professor of Biochemistry and Molecular Medicine at the University of California, Davis. His team is interested in developing innovative nanomedicine, cancer therapeutics, and molecular imaging agents that will have a tremendous impact on the treatment of cancer and other diseases. He is currently the charter member of the NIH Advancing Therapeutics A (ATA) Study Section and an elected fellow of the American Institute for Medical and Biological Engineering (AIMBE).
Speaking In
2:30 PM - 2:45 PM
Tuesday, June 6
